✦ LIBER ✦

The effects of multiple sclerosis on women's sexuality: A controlled study

✍ Scribed by Gumus, H.; Akpınar, Z.; Yılmaz, H.

Book ID: 123420923
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 76 KB
Volume: 333
Category: Article
ISSN: 0022-510X
DOI: 10.1016/j.jns.2013.07.1330

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Effects of Fibromyalgia Syndrome on

The Effects of Fibromyalgia Syndrome on Female Sexuality: A Controlled Study

✍ Halim Yilmaz; Sema Dereli Yilmaz; Halime Almula Demir Polat; Ali Salli; Gulten E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

The impact of multiple sclerosis on sexu

The impact of multiple sclerosis on sexuality and relationships

✍ McCabe, Marita P.; McDonald, Elizabeth; Deeks, Amanda A.; Vowels, Lindsay M.; Co 📂 Article 📅 1996 🏛 Taylor and Francis Group 🌐 English ⚖ 927 KB

Assessment of Sexual Satisfaction in Rel

Assessment of Sexual Satisfaction in Relation to Potential Sexual Problems in Women with Multiple Sclerosis: A Pilot Study

✍ Rashmi D. Sahay, Erin N. Haynes, M. B. Rao, Istvan Pirko 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 175 KB

The socioeconomic consequences of multip

The socioeconomic consequences of multiple sclerosis: A controlled national study

✍ Poul Jennum; Benedikte Wanscher; Jette Frederiksen; Jakob Kjellberg 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 698 KB

Effects of levetiracetam on chronic pain

Effects of levetiracetam on chronic pain in multiple sclerosis: results of a pilot, randomized, placebo-controlled study

✍ S. Rossi; G. Mataluni; C. Codecà; S. Fiore; F. Buttari; A. Musella; M. Castelli; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Azathioprine in multiple sclerosis—A 3 y

Azathioprine in multiple sclerosis—A 3 year controlled study of its effectiveness

✍ U. Patzold; P. Pocklington 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 895 KB

The results of a prospective, long-term controlled study on the treatment of multiple sclerosis with azathioprine are reported. The effect of a daily 2 mg/kg body weight dosage on 56 randomly chosen patients with multiple sclerosis is compared with a non-treated control group of 51 randomly selected